fda approval in her2 early breast cancer, fast track designation in tnbc, and more
Published 5 years ago • 216 plays • Length 11:13
Download video MP4
Download video MP3
Similar videos
-
11:00
fda approval in her2 breast cancer, priority review in nsclc, and more
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
-
4:37
cancer advance of the year, fda approval for cinv, breakthrough designation in tnbc, and more
-
19:20
fda-approved therapies for relapsed/refractory her2 mbc
-
7:21
fda approval in breast cancer, breakthrough designations in aml and bladder cancer, and more
-
7:19
fda approval in hcc, priority reviews in tnbc and ovarian cancer, snda in itp, and more
-
20:25
her2 early-stage breast cancer: peri-operative therapy
-
9:27
fda approval in bladder cancer, breakthrough therapy designation in dlbcl, and more
-
12:17
fda approvals in breast cancer and prostate cancer, priority review in breast cancer, and more
-
7:28
breakthrough designation in all, hifu fda approval, breast cancer screening update, and more
-
8:51
fda approvals in nets, breast cancer, aml, a biosimilar, and more
-
11:32
fda approvals in breast cancer and nsclc, nda accepted in hcc, and more
-
10:55
fda approvals in cinv and her2 breast cancer, priority review in myelofibrosis, and more
-
1:09:24
raising the bar in hr /her2- early breast cancer: cdk4 and 6 inhibitors
-
51:40
trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal
-
28:25
metastatic triple-negative breast cancer ongoing trials
-
31:24
harnessing the immune system in the treatment of triple-negative breast cancer
-
8:33
pending fda approval of neratinib in her2 breast cancer
-
1:05:31
adjuvant therapy for early-stage her2-positive breast cancer
Clip.africa.com - Privacy-policy